Progression-free survival among certain patients with metastatic colorectal cancer continued at a high level after immune checkpoint inhibitor therapy was stopped. Some patients with metastatic colorectal cancer who benefit from immunotherapy are reluctant to...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.” The theory has long been supplanted, but contemporary oncology has brought body fluids back into...
Stool test for signs of cancer, often collected at home, sometimes fails due to inadequate sampling, according to a study in the AACR Journal Cancer Epidemiology, Biomarkers & Prevention. About a tenth of the...
As the number of targeted cancer therapeutics has increased, the percentage of tumors carrying molecular alterations eligible for treatment by those drugs nearly doubled from 2017 to 2022. Precise, biomarker-guided therapies made up almost...
Centuries ago, when several Native tribes in northeastern America were at constant war, a peacemaker came to stop the violence. The peacemaker held up a single arrow and snapped it in front of tribal...
Intravenous delivery of antibodies may lower the risk of severe infections by 90% in patients with multiple myeloma, a recent study found. The risk of serious infection among patients receiving a new type of...
In combination with stem cell transplant, vaccination-induced immune response and was associated with long-term control of the disease. Cancer scientists have developed a vaccine that may improve the response to therapy in patients with...
“Administrative tasks” for cancer patients are linked to delayed or missed doctor visits, lab tests, prescriptions, and other services. Attempts by cancer patients to get more information about costs and health insurance coverage may...
Lorazepam used to relieve stress may cause inflammation that promotes tumor growth and shortens progression-free survival, study says. A medication commonly used to ease the stress caused by cancer diagnosis and treatment may be...
Clinical trial results suggest patients with high-risk chronic lymphocytic leukemia may benefit from a combination of two targeted therapeutics. Patients with high-risk chronic lymphocytic leukemia (CLL) may benefit from a treatment regimen that combines...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now